NCT01614574View on ClinicalTrials.gov

Study of Velaglucerase Alfa Enzyme Replacement Therapy in Japanese Patients With Gaucher Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

March 2, 2012

Primary Completion Date

May 25, 2013

Study Completion Date

May 25, 2013

Conditions
Gaucher Disease
Interventions
BIOLOGICAL

velaglucerase alfa

60 U/kg every other week intravenous infusion

Trial Locations (3)

431-3192

Hamamatsu University School of Medicine, Hamamatsu

105-8461

The Jikei University School of Medicine, Minatoku

545-0051

Osaka City University Hospital, Osaka

Sponsors

Lead Sponsor

Shire
All Listed Sponsors
lead

Shire

INDUSTRY

NCT01614574 - Study of Velaglucerase Alfa Enzyme Replacement Therapy in Japanese Patients With Gaucher Disease | Biotech Hunter | Biotech Hunter